The company said that the drug, listed on the FDA’s Current Drug Shortages list, is available in a pre-labeled, single patient, ready-to-use, tamper evident syringe admixture system, according to a company news release.
Read the PharMEDium news release about the availability of propofol.
Read more about propofol:
– BCBS of North Carolina Holds Strong on Use of Deep Sedation for Endoscopic Procedures Policy
– ASA Supports DEA Proposal to List Propofol on Schedule IV
– Impact of the Propofol Shortage on Anesthesiologists: Q&A With ASA President Alexander Hannenberg
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
